Sigma Planning Corp’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Buy |
10,747
+1,286
| +14% | +$277K | 0.06% | 311 |
|
|
2025
Q4 | $1.94M | Buy |
9,461
+2,810
| +42% | +$529K | 0.05% | 340 |
|
|
2025
Q3 | $1.04M | Sell |
6,651
-5,087
| -43% | -$786K | 0.03% | 512 |
|
|
2025
Q2 | $1.97M | Sell |
11,738
-937
| -7% | -$139K | 0.06% | 311 |
|
|
2025
Q1 | $1.75M | Buy |
12,675
+831
| +7% | +$106K | 0.06% | 316 |
|
|
2024
Q4 | $1.4M | Buy |
11,844
+413
| +4% | +$48.2K | 0.04% | 376 |
|
|
2024
Q3 | $1.26M | Buy |
11,431
+1,924
| +20% | +$201K | 0.04% | 419 |
|
|
2024
Q2 | $935K | Sell |
9,507
-732
| -7% | -$74.6K | 0.03% | 505 |
|
|
2024
Q1 | $1.15M | Buy |
10,239
+5,461
| +114% | +$589K | 0.04% | 462 |
|
|
2023
Q4 | $482K | Sell |
4,778
-1,426
| -23% | -$141K | 0.04% | 465 |
|
|
2023
Q3 | $539K | Sell |
6,204
-64
| -1% | -$5.79K | 0.02% | 685 |
|
|
2023
Q2 | $593K | Sell |
6,268
-613
| -9% | -$51.8K | 0.02% | 660 |
|
|
2023
Q1 | $520K | Buy |
6,881
+531
| +8% | +$40.1K | 0.02% | 776 |
|
|
2022
Q4 | $488K | Buy |
6,350
+520
| +9% | +$39.5K | 0.02% | 770 |
|
|
2022
Q3 | $389K | Sell |
5,830
-802
| -12% | -$50.8K | 0.01% | 834 |
|
|
2022
Q2 | $347K | Sell |
6,632
-1,397
| -17% | -$79.4K | 0.01% | 921 |
|
|
2022
Q1 | $455K | Buy |
8,029
+730
| +10% | +$39.1K | 0.01% | 876 |
|
|
2021
Q4 | $376K | Buy |
7,299
+287
| +4% | +$14.1K | 0.01% | 972 |
|
|
2021
Q3 | $347K | Buy |
7,012
+477
| +7% | +$25.9K | 0.01% | 983 |
|
|
2021
Q2 | $373K | Buy |
6,535
+2,371
| +57% | +$139K | 0.01% | 969 |
|
|
2021
Q1 | $253K | Sell |
4,164
-2,259
| -35% | -$125K | 0.01% | 1084 |
|
|
2020
Q4 | $344K | Sell |
6,423
-7,533
| -54% | -$391K | 0.01% | 832 |
|
|
2020
Q3 | $655K | Buy |
13,956
+6,056
| +77% | +$311K | 0.03% | 520 |
|
|
2020
Q2 | $412K | Sell |
7,900
-10,616
| -57% | -$547K | 0.02% | 664 |
|
|
2020
Q1 | $888K | Sell |
18,516
-1,340
| -7% | -$69.6K | 0.05% | 350 |
|
|
2019
Q4 | $1M | Sell |
19,856
-7,063
| -26% | -$365K | 0.04% | 407 |
|
|
2019
Q3 | $1.27M | Buy |
26,919
+6,461
| +32% | +$295K | 0.06% | 319 |
|
|
2019
Q2 | $964K | Buy |
20,458
+2,448
| +14% | +$113K | 0.05% | 348 |
|
|
2019
Q1 | $867K | Buy |
18,010
+7,160
| +66% | +$359K | 0.05% | 351 |
|
|
2018
Q4 | $484K | Buy |
10,850
+5,908
| +120% | +$308K | 0.04% | 453 |
|
|
2018
Q3 | $267K | Sell |
4,942
-3,708
| -43% | -$190K | 0.02% | 748 |
|
|
2018
Q2 | $422K | Buy |
8,650
+1,256
| +17% | +$71.2K | 0.03% | 508 |
|
|
2018
Q1 | $464K | Buy |
7,394
+2,250
| +44% | +$154K | 0.03% | 455 |
|
|
2017
Q4 | $315K | Sell |
5,144
-2,545
| -33% | -$157K | 0.02% | 584 |
|
|
2017
Q3 | $515K | Buy |
+7,689
| New | +$544K | 0.04% | 418 |
|
|
2016
Q4 | – | Sell |
-2,976
| Closed | -$231K | – | 750 |
|
|
2016
Q3 | $231K | Buy |
2,976
+248
| +9% | +$20K | 0.03% | 599 |
|
|
2016
Q2 | $213K | Buy |
+2,728
| New | +$217K | 0.03% | 595 |
|
|
2015
Q3 | – | Sell |
-2,508
| Closed | -$210K | – | 684 |
|
|
2015
Q2 | $210K | Buy |
+2,508
| New | +$221K | 0.03% | 608 |
|
Other funds holding CAH
VCM
VPM
Sigma Planning Corp's CAH Position: Q1 2026 in Review
Sigma Planning Corp increased its Cardinal Health (CAH) stake by 14% in Q1 2026, buying an estimated $277K and bringing the position to 10,747 shares worth $2.27M. The position accounts for 0.06% of the portfolio, ranked #311.
Sigma Planning Corp first reported a position in CAH in Q2 2015 and has held it in 38 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Sigma Planning Corp held 10,747 shares of Cardinal Health worth $2.27M as of Q1 2026.
- Sigma Planning Corp bought 1,286 Cardinal Health shares in Q1 2026, an estimated $277K.
- Cardinal Health made up 0.06% of Sigma Planning Corp's portfolio in Q1 2026, its #311 holding.
- Sigma Planning Corp first reported a position in Cardinal Health in Q2 2015 and has held it in 38 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.